Mercy Research
20
0
1
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
25.0%
5 terminated/withdrawn out of 20 trials
73.7%
-12.8% vs industry average
5%
1 trials in Phase 3/4
86%
12 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Subclinical Lymphedema Treatment Study
Role: lead
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
Role: collaborator
Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy
Role: lead
Effect of Ultrasound Guided Laser Ablation Therapy on Symptomatic Benign Thyroid Nodules
Role: collaborator
Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis
Role: lead
Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®
Role: lead
Stereotactic Body Radiotherapy for Prostate Cancer
Role: lead
Patient Anxiety Associated With Lymphedema Surveillance Method
Role: lead
VitalConnect VitalPatch ECG Interpretation/Arrhythmia Detection
Role: lead
Stereotactic Body Radiotherapy for Spine Tumors
Role: lead
Stereotactic Body Radiotherapy for Head and Neck Tumors
Role: lead
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
Role: lead
Stereotactic Body Radiotherapy for Liver Tumors
Role: lead
Surgical Treatment Comparison for Recurrent Lumbar Disc Herniation
Role: lead
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
Role: lead
Psychosocial Factors of Burn Related Injuries and Perceived Gaps in Service Delivery
Role: collaborator
A Comparison of Meperidine for Post-Cesarean Analgesia: Bolus Versus Infusion and Bolus
Role: lead
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
Role: lead
Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
Role: lead
The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock Patients
Role: lead
All 20 trials loaded